Hyungwoo Cho
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Anbalcabtagene Autoleucel in Relapsed/Refractory CNS Lymphoma (NCT07062627) | Hyungwoo Cho | 2025-11-12 |
Track Hyungwoo Cho automatically
Every clearance here is in the API, with alerts when new ones post.